CYPRESS BIOSCIENCE INC
10-Q, EX-27.1, 2000-11-14
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CYPRESS BIOSCIENCE INC, 10-Q, 2000-11-14
Next: BROADWING INC, 10-Q, 2000-11-14



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             JUL-01-2000             JAN-01-2000
<PERIOD-END>                               SEP-30-2000             SEP-30-2000
<CASH>                                           8,956                   8,956
<SECURITIES>                                         0                       0
<RECEIVABLES>                                      373                     373
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                 9,581                   9,581
<PP&E>                                             606                     606
<DEPRECIATION>                                   (443)                   (443)
<TOTAL-ASSETS>                                   9,777                   9,777
<CURRENT-LIABILITIES>                            3,174                   3,174
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                           974                     974
<OTHER-SE>                                      99,326                  99,326
<TOTAL-LIABILITY-AND-EQUITY>                     9,777                   9,777
<SALES>                                              0                       0
<TOTAL-REVENUES>                                   889                   2,304
<CGS>                                              150                     330
<TOTAL-COSTS>                                    2,770                   9,272
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 135                     430
<INCOME-PRETAX>                                (1,859)                 (6,889)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                            (1,859)                 (6,889)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                   (1,859)                 (6,889)
<EPS-BASIC>                                      (.04)                   (.14)
<EPS-DILUTED>                                    (.04)                   (.14)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission